Approvals/TGA/ICLUSIG ponatinib (as hydrochloride) 15 mg film-coated tablet bottle

Approved

STANDARD

ICLUSIG ponatinib (as hydrochloride) 15 mg film-coated tablet bottle

Takeda Pharmaceuticals Australia Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: a17b600cc386a613
Product Name: ICLUSIG ponatinib (as hydrochloride) 15 mg film-coated tablet bottle
Artg Id: 212583
Artg Name: ICLUSIG ponatinib (as hydrochloride) 15 mg film-coated tablet bottle
Sponsor: Takeda Pharmaceuticals Australia Pty Ltd
Company Detail Path: /organization/takeda-pharmaceuticals-australia-pty-ltd
Artg Date: 2014-11-26
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: https://medical-cdn.nocode.com/drug_tga/4e8bbbbcfbb588463442a0beae287c7d.pdf
Product Information: https://medical-cdn.nocode.com/drug_tga/f92b074f7bbc3c0cb7d1d6fc1fe9daa8.pdf

Approved

Agency

TGA

Country

🇦🇺

Approval Date

May 30, 2025

Approval ID

a17b600cc386a613

Type

Standard